固形がん治療の世界市場レポート 2025年

固形がん治療市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR13.6％で4,427億9,000万米ドルに成長します。予測期間の成長は、個別化医療の動向、免疫療法の進歩、世界の健康課題と新興疾患、規制の枠組みと医薬品承認、ヘルスケア財政と償還モデルのシフトに起因すると考えられます。予測期間における主な動向には、免疫療法の進歩、精密医療とバイオマーカー同定、併用療法、デジタルヘルス統合、治療法における技術革新などがあります。

がんの罹患率の上昇は、今後数年間の固形がん治療市場の成長を大きく牽引すると予想されます。がんは、体細胞の急速かつ制御不能な再生産を特徴とする深刻な病態であり、異常増殖につながります。固形がん治療は、がん患者の体内から固形腫瘍を除去することを目的とした治療法を指します。例えば、スイスに本部を置く国際的な公衆衛生機関である世界保健機関（WHO）の報告書によると、2022年には新たに2,000万人近くのがん患者が報告され、この病気による死亡者は約1,000万人に上るといいます。人口統計学的予測によれば、2050年にはがんの年間罹患数は3,500万人に達する可能性があり、これは2022年の水準から77％の増加です。肺がんは最も多く診断されるがんで、約250万人の新規症例、すなわち世界のがんの8人に1人を占め、これは世界の全がんの12.4％を占める。このように、がんの罹患率の増加は、固形がん治療市場の成長を促進する重要な要因です。

人口の増加は、今後数年間の固形がん治療市場の拡大を促進すると予測されています。高齢化とは、時間の経過とともに社会における高齢者の割合が増加することを特徴とする人口動態の変化を指します。固形がん治療は、様々な種類の固形がんと診断された高齢者が直面する特有の課題や複雑さに対処するために特別に設計されています。例えば、ケニアを拠点とする非営利団体である人口問題研究所の報告書によると、65歳以上のアメリカ人の人口は、2022年の5,800万人から2050年には8,200万人へと47％増加すると予想されています。さらに、人口全体に占めるこの年齢層の割合は、同じ期間に17％から23％に増加すると予測されています。したがって、高齢化人口の増加が固形がん治療市場の成長を牽引する重要な要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界固形がん治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界の固形がん治療市場：成長率分析
• 世界の固形がん治療市場の実績：規模と成長, 2019-2024
• 世界の固形がん治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界固形がん治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の固形がん治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学療法
• 標的療法
• 免疫療法
• ホルモン療法
• 外科手術
• 世界の固形がん治療市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 乳がん
• 子宮頸がん
• 大腸がん
• 肺がん
• 前立腺がん
• その他の用途
• 世界の固形がん治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 調査機関
• ホームケア
• 世界の固形がん治療市場化学療法の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• アルキル化剤
• 代謝拮抗物質
• アントラサイクリン
• 有糸分裂阻害剤
• 世界の固形がん治療市場、標的療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• モノクローナル抗体
• 低分子阻害剤
• シグナル伝達阻害剤
• 世界の固形がん治療市場、免疫療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• チェックポイント阻害剤
• CAR T細胞療法
• がんワクチン
• 世界の固形がん治療市場ホルモン療法の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• アロマターゼ阻害剤
• 抗アンドロゲン
• 選択的エストロゲン受容体モジュレーター（SERM）
• 世界の固形がん治療市場、手術方法の細分化、種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍切除
• 腹腔鏡手術
• ロボット支援手術

第7章 地域別・国別分析

• 世界の固形がん治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の固形がん治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 固形がん治療市場：競合情勢
• 固形がん治療市場：企業プロファイル
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol Myers Squibb & Company Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly & Company Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Olympus Medical Systems
• Astellas Pharma Inc.
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Ltd.
• Celldex Therapeutics Inc.
• AbbVie Inc.
• Bayer AG
• Biogen Inc.
• Eisai Co. Ltd.
• Exelixis Inc.
• Genentech Inc.
• Gilead Sciences Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 固形がん治療市場2029：新たな機会を提供する国
• 固形がん治療市場2029：新たな機会を提供するセグメント
• 固形がん治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Solid tumor cancer treatment pertains to addressing abnormal tissue masses that typically lack cysts or liquid regions. These tumors encompass various organs such as the brain, ovary, breast, colon, and others. The proliferation of tumor cells is primarily driven by cancer stem cells undergoing division.

The principal treatments for solid tumor cancer encompass chemotherapy, targeted therapy, immunotherapy, hormone therapy, and surgical interventions. Chemotherapy involves drug-based therapies aimed at halting cell division or eliminating cancer cells to impede their growth. Its applications extend across various cancer types such as breast, cervical, colorectal, lung, prostate, among others. These treatments are utilized across diverse end-users such as hospitals, research institutes, and home care settings.

The solid tumor cancer treatment market research report is one of a series of new reports from The Business Research Company that provides solid tumor cancer treatment market statistics, including solid tumor cancer treatment industry global market size, regional shares, competitors with a solid tumor cancer treatment market share, detailed solid tumor cancer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the solid tumor cancer treatment industry. This solid tumor cancer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The solid tumor cancer treatment market size has grown rapidly in recent years. It will grow from $232.2 billion in 2024 to $266.16 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to advancements in research and development, drug development and approvals, increased cancer incidence rates, growing aging population, patient advocacy and awareness.

The solid tumor cancer treatment market size is expected to see rapid growth in the next few years. It will grow to $442.79 billion in 2029 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to personalized medicine trends, immunotherapy advancements, global health challenges and emerging diseases, regulatory frameworks and drug approvals, shifts in healthcare financing and reimbursement models. Major trends in the forecast period include immunotherapy advancements, precision medicine and biomarker identification, combination therapies, digital health integration, technological innovations in treatment modalities.

The rising incidence of cancer is expected to significantly drive the growth of the solid tumor cancer treatment market in the coming years. Cancer is a serious condition characterized by the rapid and uncontrolled reproduction of the body's cells, leading to abnormal growths. Solid tumor cancer treatment refers to therapies aimed at removing solid tumors from the bodies of cancer patients. For example, a report from the World Health Organization, a Switzerland-based international public health agency, indicated that in 2022, nearly 20 million new cancer cases were reported, resulting in approximately 10 million deaths from the disease. Demographic projections suggest that the annual incidence of cancer could reach 35 million by 2050, representing a 77% increase from 2022 levels. Lung cancer was the most frequently diagnosed type, accounting for around 2.5 million new cases, or one in every eight cancers globally, which constitutes 12.4% of all cancers worldwide. Thus, the increasing incidence of cancer is a key factor driving the growth of the solid tumor cancer treatment market.

The growing population is projected to drive the expansion of the solid tumor cancer treatment market in the coming years. An aging population refers to a demographic shift characterized by an increasing proportion of elderly individuals within a society over time. Solid tumor cancer treatment is specifically designed to address the unique challenges and complexities faced by older adults diagnosed with various types of solid tumors. For example, a report from the Population Reference Bureau, a Kenya-based nonprofit organization, noted that the population of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, the share of this age group within the overall population is projected to grow from 17% to 23% during the same timeframe. Therefore, the increasing aging population is a significant factor driving the growth of the solid tumor cancer treatment market.

Innovation in products and treatments has emerged as a notable trend in the solid tumor cancer treatment market, with major companies actively focusing on introducing new solutions to sustain their market positions. An illustrative example is Shanghai Henlius Biotech, a China-based biopharmaceutical company, which launched the PD-1 inhibitor HANSIZHUANG in March 2022. HANSIZHUANG, the company's first innovative monoclonal antibody, was developed for treating adults with advanced, unresectable, or metastatic MSI-H (microsatellite instability-high) solid tumors unresponsive to prior conventional treatments. This product innovation not only provides fresh hope for patients with MSI-H solid tumors but also aligns with the demand for precision immunotherapy, fostering the high-quality development of China's biopharmaceutical industry in the solid tumor cancer treatment market.

Prominent companies in the solid tumor cancer treatment market are directing their focus towards the development of monitoring platforms that leverage tailored tests, including personalized assays, for precise detection. Personalized assays involve customized laboratory tests or analytical procedures designed to examine specific characteristics or markers unique to an individual, often based on their genetic or molecular profile. An exemplary illustration is Invitae, a US-based medical genetics company, which, in collaboration with the Tracerx consortium at University College London, launched a personalized cancer monitoring platform in March 2022. This platform is specifically designed for the detection of minimal or molecular residual disease in patients with solid tumors. Utilizing personalized assays based on the patient's tumor, the platform identifies circulating tumor DNA (ctDNA) in the blood. These assays play a crucial role in helping clinicians assess patient risk, gauge treatment response, and predict the likelihood of recurrence.

In February 2024, AbbVie Inc., a U.S.-based pharmaceutical company, acquired ImmunoGen, Inc. This acquisition is part of AbbVie's strategy to bolster its oncology capabilities by specifically targeting unmet needs in cancer treatments. The company aims to enhance its solid tumor portfolio and expand its footprint in the oncology market. ImmunoGen, Inc. is a U.S.-based biotechnology firm specializing in the development of antibody-drug conjugate (ADC) therapeutics for cancer treatment.

Major companies operating in the solid tumor cancer treatment market include AstraZeneca plc, Amgen Inc., Bristol Myers Squibb & Company, Eli Lilly & Company, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Olympus Medical Systems, Astellas Pharma Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Ltd., Celldex Therapeutics Inc., AbbVie Inc., Bayer AG, Biogen Inc., Eisai Co. Ltd., Exelixis Inc., Genentech Inc., Gilead Sciences Inc., Incyte Corporation, Ipsen Biopharmaceuticals Inc., Karyopharm Therapeutics Inc., Kyowa Kirin Co. Ltd., MorphoSys AG, Regeneron Pharmaceuticals Inc., Sanofi SA, Seattle Genetics Inc., Spectrum Pharmaceuticals Inc., Taiho Pharmaceutical Co. Ltd., Verastem Inc., Zymeworks Inc.

North America was the largest region in the solid tumor cancer treatment market in 2024. The regions covered in the solid tumor cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the solid tumor cancer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The solid tumor cancer treatment market includes revenues earned by entities by treat solid tumor cancer through hormonal therapy, targeted drugs, and immunotherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Solid Tumor Cancer Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on solid tumor cancer treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for solid tumor cancer treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The solid tumor cancer treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Chemotherapy; Targeted Therapy; Immunotherapy; Hormone Therapy; Surgical Procedures
• 2) By Application: Breast Cancer; Cervical Cancer; Colorectal Cancer; Lung Cancer; Prostate Cancer; Other Applications
• 3) By End-Users: Hospitals; Research Institutes; Homecare
• Subsegments:
• 1) By Chemotherapy: Alkylating Agents; Antimetabolites; Anthracyclines; Mitotic Inhibitors
• 2) By Targeted Therapy: Monoclonal Antibodies; Small Molecule Inhibitors; Signal Transduction Inhibitors
• 3) By Immunotherapy: Checkpoint Inhibitors; CAR T-Cell Therapy; Cancer Vaccines
• 4) By Hormone Therapy: Aromatase Inhibitors; Anti-Androgens; Selective Estrogen Receptor Modulators (SERMs)
• 5) By Surgical Procedures: Tumor Resection; Laparoscopic Surgery; Robotic-Assisted Surgery
• Companies Mentioned: AstraZeneca plc; Amgen Inc.; Bristol Myers Squibb & Company; Eli Lilly & Company; F. Hoffmann-La Roche Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Solid Tumor Cancer Treatment Market Characteristics

3. Solid Tumor Cancer Treatment Market Trends And Strategies

4. Solid Tumor Cancer Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Solid Tumor Cancer Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Solid Tumor Cancer Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Solid Tumor Cancer Treatment Market Growth Rate Analysis
• 5.4. Global Solid Tumor Cancer Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Solid Tumor Cancer Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Solid Tumor Cancer Treatment Total Addressable Market (TAM)

6. Solid Tumor Cancer Treatment Market Segmentation

• 6.1. Global Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Hormone Therapy
• Surgical Procedures
• 6.2. Global Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breast Cancer
• Cervical Cancer
• Colorectal Cancer
• Lung Cancer
• Prostate Cancer
• Other Applications
• 6.3. Global Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Research Institutes
• Homecare
• 6.4. Global Solid Tumor Cancer Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alkylating Agents
• Antimetabolites
• Anthracyclines
• Mitotic Inhibitors
• 6.5. Global Solid Tumor Cancer Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Small Molecule Inhibitors
• Signal Transduction Inhibitors
• 6.6. Global Solid Tumor Cancer Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Checkpoint Inhibitors
• CAR T-Cell Therapy
• Cancer Vaccines
• 6.7. Global Solid Tumor Cancer Treatment Market, Sub-Segmentation Of Hormone Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aromatase Inhibitors
• Anti-Androgens
• Selective Estrogen Receptor Modulators (SERMs)
• 6.8. Global Solid Tumor Cancer Treatment Market, Sub-Segmentation Of Surgical Procedures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tumor Resection
• Laparoscopic Surgery
• Robotic-Assisted Surgery

7. Solid Tumor Cancer Treatment Market Regional And Country Analysis

• 7.1. Global Solid Tumor Cancer Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Solid Tumor Cancer Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Solid Tumor Cancer Treatment Market

• 8.1. Asia-Pacific Solid Tumor Cancer Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Solid Tumor Cancer Treatment Market

• 9.1. China Solid Tumor Cancer Treatment Market Overview
• 9.2. China Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Solid Tumor Cancer Treatment Market

• 10.1. India Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Solid Tumor Cancer Treatment Market

• 11.1. Japan Solid Tumor Cancer Treatment Market Overview
• 11.2. Japan Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Solid Tumor Cancer Treatment Market

• 12.1. Australia Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Solid Tumor Cancer Treatment Market

• 13.1. Indonesia Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Solid Tumor Cancer Treatment Market

• 14.1. South Korea Solid Tumor Cancer Treatment Market Overview
• 14.2. South Korea Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Solid Tumor Cancer Treatment Market

• 15.1. Western Europe Solid Tumor Cancer Treatment Market Overview
• 15.2. Western Europe Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Solid Tumor Cancer Treatment Market

• 16.1. UK Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Solid Tumor Cancer Treatment Market

• 17.1. Germany Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Solid Tumor Cancer Treatment Market

• 18.1. France Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Solid Tumor Cancer Treatment Market

• 19.1. Italy Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Solid Tumor Cancer Treatment Market

• 20.1. Spain Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Solid Tumor Cancer Treatment Market

• 21.1. Eastern Europe Solid Tumor Cancer Treatment Market Overview
• 21.2. Eastern Europe Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Solid Tumor Cancer Treatment Market

• 22.1. Russia Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Solid Tumor Cancer Treatment Market

• 23.1. North America Solid Tumor Cancer Treatment Market Overview
• 23.2. North America Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Solid Tumor Cancer Treatment Market

• 24.1. USA Solid Tumor Cancer Treatment Market Overview
• 24.2. USA Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Solid Tumor Cancer Treatment Market

• 25.1. Canada Solid Tumor Cancer Treatment Market Overview
• 25.2. Canada Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Solid Tumor Cancer Treatment Market

• 26.1. South America Solid Tumor Cancer Treatment Market Overview
• 26.2. South America Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Solid Tumor Cancer Treatment Market

• 27.1. Brazil Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Solid Tumor Cancer Treatment Market

• 28.1. Middle East Solid Tumor Cancer Treatment Market Overview
• 28.2. Middle East Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Solid Tumor Cancer Treatment Market

• 29.1. Africa Solid Tumor Cancer Treatment Market Overview
• 29.2. Africa Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Solid Tumor Cancer Treatment Market Competitive Landscape And Company Profiles

• 30.1. Solid Tumor Cancer Treatment Market Competitive Landscape
• 30.2. Solid Tumor Cancer Treatment Market Company Profiles
  • 30.2.1. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bristol Myers Squibb & Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eli Lilly & Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Solid Tumor Cancer Treatment Market Other Major And Innovative Companies

• 31.1. Merck & Co. Inc.
• 31.2. Novartis AG
• 31.3. Pfizer Inc.
• 31.4. Olympus Medical Systems
• 31.5. Astellas Pharma Inc.
• 31.6. GlaxoSmithKline plc
• 31.7. Takeda Pharmaceutical Company Ltd.
• 31.8. Celldex Therapeutics Inc.
• 31.9. AbbVie Inc.
• 31.10. Bayer AG
• 31.11. Biogen Inc.
• 31.12. Eisai Co. Ltd.
• 31.13. Exelixis Inc.
• 31.14. Genentech Inc.
• 31.15. Gilead Sciences Inc.

32. Global Solid Tumor Cancer Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Solid Tumor Cancer Treatment Market

34. Recent Developments In The Solid Tumor Cancer Treatment Market

35. Solid Tumor Cancer Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Solid Tumor Cancer Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Solid Tumor Cancer Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Solid Tumor Cancer Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer